3 completed, 3 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 2 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Stem Cell Factor: new trials by email Literature Review of Stem Cell Factor trials Research Report on Stem Cell Factor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer aldesleukin, recombinant human stem cell factor - Lymphoma | Phase 1 | Completed | Roswell Park Cancer Institute | 1 | 2002-08-01 | 2013-01-31 |
| Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer filgrastim, recombinant flt3 ligand, recombinant human thrombopoietin - Breast Cancer, Leukemia | Phase 1 / Phase 2 | Completed | Northwestern University | 1999-11-01 | 2012-06-06 | |
| Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma epoetin alfa, filgrastim, recombinant flt3 ligand - Lymphoma, Neutropenia | Phase 1 | Terminated | Northwestern University | 3 | 1999-09-01 | 2012-06-01 |
| Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer aldesleukin, filgrastim, recombinant human stem cell factor - Breast Cancer, Lymphoma | Phase 1 | Terminated | Masonic Cancer Center, University of Minnesota | 1999-05-01 | 2017-11-29 | |
| Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma r-metHuSCF and Filgrastim, Chemotherapy plus Filgrastim - Malignant Lymphoma | Phase 2 | Terminated | Aalborg University Hospital | 32 | 1999-01-01 | 2015-06-25 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma filgrastim, recombinant human stem cell factor, cyclophosphamide - Lymphoma | Phase 2 | Completed | Fox Chase Cancer Center | 3 | 1998-12-01 | 2013-04-17 |
Lymphoma (6) · Lymphoma, Follicular (4) · Lymphoma, Large B-Cell, Diffuse (4) · Lymphoma, Large-Cell, Immunoblastic (4) · Lymphoma, Non-Hodgkin (4) · Burkitt Lymphoma (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Mantle-Cell (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Breast Neoplasms (2) · Hodgkin Disease (2) · Breast Neoplasms, Male (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1)
Northwestern University (2) · Aalborg University Hospital (1) · Fox Chase Cancer Center (1) · Masonic Cancer Center, University of Minnesota (1) · Roswell Park Cancer Institute (1)
United States (4) · Denmark (1) · Finland (1) · Norway (1) · Sweden (1)
Jane N. Winter, MD (2) · Hans E Johnsen, MD DMSc (1) · Linda J. Burns, MD (1) · Russell J. Schilder, MD (1) · Zale P. Bernstein, MD (1)